Friday, April 19, 2024
4/19/2024
Our laboratory has pioneered the use of blood oxygenation level dependent (BOLD) MRI the kidneys as a way of evaluating its oxygenation status. Several investigators around the world have validated the technique. However, it remains as a qualitative measure and its specificity to oxygenation is not validated. Even though it is known theoretically that a role exists for the fractional blood volume (fraction of the tissue occupied by blood vessels) in BOLD MRI, with the lack of data it has been tacitly assumed to be either small or non-existent. However, recent developments allow us to measure regional fBV using blood pool contrast agents. Here, we want to for the first time measure regional fBV in human kidneys and see (i) whether it is different in cortex and medulla; (ii) whether medullary fBV reduces when administering furosemide as suggested by recent data in rat kidneys; and (iii) whether regional fBV is reduced in individuals with chronic kidney disease (CKD). If the proposed study is successful, it may support the use of fBV as an independent imaging marker. In addition, the data will have a significant impact on the interpretation of renal BOLD MRI data.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
